323 related articles for article (PubMed ID: 36341437)
21. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma.
Zhang L; Xu J; Chu X; Zhang H; Yao X; Zhang J; Guo Y
BMC Bioinformatics; 2022 Nov; 23(1):485. PubMed ID: 36384423
[TBL] [Abstract][Full Text] [Related]
22. A novel Cuprotosis-related signature predicts the prognosis and selects personal treatments for melanoma based on bioinformatics analysis.
Hu B; Hounye AH; Wang Z; Qi M; Zhang J
Front Oncol; 2023; 13():1108128. PubMed ID: 36824136
[TBL] [Abstract][Full Text] [Related]
23. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.
Chen Y; Chen X; Wang X
Front Cell Dev Biol; 2022; 10():973073. PubMed ID: 36111345
[TBL] [Abstract][Full Text] [Related]
24. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.
Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH
Front Immunol; 2022; 13():999849. PubMed ID: 36211401
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions.
Chen G; Luo D; Qi X; Li D; Zheng J; Luo Y; Zhang C; Ren Q; Lu Y; Chan YT; Chen B; Wu J; Wang N; Feng Y
Front Cell Dev Biol; 2023; 11():1172895. PubMed ID: 37351275
[TBL] [Abstract][Full Text] [Related]
26. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
[TBL] [Abstract][Full Text] [Related]
27. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer.
Yang L; Tang Y; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Sci Rep; 2024 Apr; 14(1):9570. PubMed ID: 38671021
[TBL] [Abstract][Full Text] [Related]
28. Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC.
Wang Y; Zhang Y; Wang L; Zhang N; Xu W; Zhou J; Zhao Y; Zhu W; Zhang T; Wang L
Hepatol Int; 2022 Dec; 16(6):1435-1447. PubMed ID: 36065073
[TBL] [Abstract][Full Text] [Related]
29. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma.
Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H
Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of Cuproptosis-Related Gene Signatures in Breast Cancer Based on Transcriptomic Data Analysis.
Zhou Z; Deng J; Pan T; Zhu Z; Zhou X; Lv C; Li H; Peng W; Lin B; Cai C; Wang H; Cai Y; Wei F; Zhou G
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497253
[TBL] [Abstract][Full Text] [Related]
32. Identification of cuproptosis-related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma.
Huang J; Xu Z; Yuan Z; Cheng L; Zhou C; Shen Y
J Clin Lab Anal; 2022 Sep; 36(9):e24638. PubMed ID: 36082469
[TBL] [Abstract][Full Text] [Related]
33. Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma.
Liu X; Sun B; Yao Y; Lai L; Wang X; Xiong J; Zhang X; Jiang J
Front Immunol; 2022; 13():996308. PubMed ID: 36275743
[TBL] [Abstract][Full Text] [Related]
34. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
Front Genet; 2023; 14():1124439. PubMed ID: 36936439
[No Abstract] [Full Text] [Related]
35. Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes.
Zhao B; Wu W; Liang L; Cai X; Chen Y; Tang W
Heliyon; 2023 Aug; 9(8):e19035. PubMed ID: 37636385
[TBL] [Abstract][Full Text] [Related]
36. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
[TBL] [Abstract][Full Text] [Related]
37. Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis.
Wang M; Cheng L; Xiang Q; Gao Z; Ding Y; Xie H; Chen X; Yu P; Shen L
Heliyon; 2023 Oct; 9(10):e21158. PubMed ID: 37928399
[TBL] [Abstract][Full Text] [Related]
38. A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer.
Du Y; Jiang W; Hou S; Chen Z; Zhou W
Biomed Res Int; 2023; 2023():3419401. PubMed ID: 36714025
[TBL] [Abstract][Full Text] [Related]
39. A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC.
Tang Y; Wang T; Li Q; Shi J
Cancer Cell Int; 2024 Feb; 24(1):68. PubMed ID: 38341588
[TBL] [Abstract][Full Text] [Related]
40. The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma.
Li K; Wu LL; Wang H; Cheng H; Zhuo HM; Hao Y; Liu ZY; Li CW; Qian JY; Li ZX; Xie D; Chen C
Front Oncol; 2022; 12():1011568. PubMed ID: 36505852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]